Advice to Whistleblowers

In your May 15, 1995 article entitled "Veteran Whistleblowers Advise Other Would-Be 'Ethical Resisters' to Carefully Weigh Personal Consequences Before Taking Action" [F. Hoke, page 1], you indicate that some have said that the National Academy of Sciences' advice in its guidance document, On Being a Scientist: Responsible Conduct in Research, regarding reporting instances of misconduct, was "facile, even irresponsible." In summarizing the advice, you indicate that the academy advises beginnin

Written byPhillip Sharp
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In summarizing the advice, you indicate that the academy advises beginning researchers that "if they suspect a colleague of violating the ethical standards of the scientific community, they have 'an unmistakable obligation to act'-that is, to blow the whistle on the misconduct." Your article suggests that the consequences of such action were not adequately considered in the report. However, throughout the document we felt a responsibility to be fair and honest with young scientists making difficult decisions concerning misconduct.

As chairman of the committee that developed this project, I would like to point out two shortcomings of this article:

First, the full context of the section that describes how to respond to violations of ethical standards was not presented. I would encourage readers to refer to the entire section and the related case study, and its discussion. Briefly, your summary of the committee's guidance failed to go beyond the first ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies